Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of enhancing anti-tumor immunity by administering antibodies to the CCRL2 chemerin receptor

Methods of enhancing anti-tumor immunity by administering antibodies to the CCRL2 chemerin receptor

US Patent 9868792 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising chemerin and methods of use thereof2024
Compositions comprising chemerin and methods of use thereof2024
Small molecule CMKLR1 antagonists in inflammatory disease2023
BTLA-binding antibodies for modulating immune response and treating disease2022
DGAT1 inhibition for treatment of demyelinating inflammatory disease2019
Function homology screening2018
Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy2016
Small molecule CMKLR1 antagonists in demyelinating disease2016
Small molecule CMKLR1 antagonists in demyelinating disease2016
Tolerogenic populations of dendritic cells2014
Function homology screening2013
Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy2013